Report cover image

Global Flu Shots Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 191 Pages
SKU # APRC20552397

Description

Summary

According to APO Research, The global Flu Shots market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Flu Shots is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flu Shots, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Flu Shots, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Shots, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Shots sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Flu Shots market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Flu Shots sales, projected growth trends, production technology, application and end-user industry.

Flu Shots Segment by Company

SANOFI
GSK
VAXTEC
TIANYUAN BIO-PHARMA
SIOBP
SINOVAC
LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
HUALAN BIO
CHANGSHENG
CCBIO
ALEPH BIOMEDICAL
Flu Shots Segment by Type

Influenza Whole Virus Vaccines
Influenza Virus Subunit Vaccines
Influenza Virus Split Vaccines
Flu Shots Segment by Application

Avian Influenza Virus-A
Avian Influenza Virus-B
Flu Shots Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flu Shots market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Flu Shots Market Size, 2020 VS 2024 VS 2031
1.3 Global Flu Shots Market Size Estimates and Forecasts (2020-2031)
1.4 Global Flu Shots Sales Estimates and Forecasts (2020-2031)
1.5 Global Flu Shots Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Flu Shots Market Dynamics
2.1 Flu Shots Industry Trends
2.2 Flu Shots Industry Drivers
2.3 Flu Shots Industry Opportunities and Challenges
2.4 Flu Shots Industry Restraints
3 Flu Shots Market by Manufacturers
3.1 Global Flu Shots Revenue by Manufacturers (2020-2025)
3.2 Global Flu Shots Sales by Manufacturers (2020-2025)
3.3 Global Flu Shots Average Sales Price by Manufacturers (2020-2025)
3.4 Global Flu Shots Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Flu Shots Manufacturers, Product Type & Application
3.7 Global Flu Shots Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Flu Shots Market CR5 and HHI
3.8.2 Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2024
3.8.3 2024 Flu Shots Tier 1, Tier 2, and Tier 3
4 Flu Shots Market by Type
4.1 Flu Shots Type Introduction
4.1.1 Influenza Whole Virus Vaccines
4.1.2 Influenza Virus Subunit Vaccines
4.1.3 Influenza Virus Split Vaccines
4.2 Global Flu Shots Sales by Type
4.2.1 Global Flu Shots Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Flu Shots Sales by Type (2020-2031)
4.2.3 Global Flu Shots Sales Market Share by Type (2020-2031)
4.3 Global Flu Shots Revenue by Type
4.3.1 Global Flu Shots Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Flu Shots Revenue by Type (2020-2031)
4.3.3 Global Flu Shots Revenue Market Share by Type (2020-2031)
5 Flu Shots Market by Application
5.1 Flu Shots Application Introduction
5.1.1 Avian Influenza Virus-A
5.1.2 Avian Influenza Virus-B
5.2 Global Flu Shots Sales by Application
5.2.1 Global Flu Shots Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Flu Shots Sales by Application (2020-2031)
5.2.3 Global Flu Shots Sales Market Share by Application (2020-2031)
5.3 Global Flu Shots Revenue by Application
5.3.1 Global Flu Shots Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Flu Shots Revenue by Application (2020-2031)
5.3.3 Global Flu Shots Revenue Market Share by Application (2020-2031)
6 Global Flu Shots Sales by Region
6.1 Global Flu Shots Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Flu Shots Sales by Region (2020-2031)
6.2.1 Global Flu Shots Sales by Region (2020-2025)
6.2.2 Global Flu Shots Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Flu Shots Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Flu Shots Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Flu Shots Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Flu Shots Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Flu Shots Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Flu Shots Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Flu Shots Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Flu Shots Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Flu Shots Revenue by Region
7.1 Global Flu Shots Revenue by Region
7.1.1 Global Flu Shots Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Flu Shots Revenue by Region (2020-2025)
7.1.3 Global Flu Shots Revenue by Region (2026-2031)
7.1.4 Global Flu Shots Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Flu Shots Revenue (2020-2031)
7.2.2 North America Flu Shots Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Flu Shots Revenue (2020-2031)
7.3.2 Europe Flu Shots Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Flu Shots Revenue (2020-2031)
7.4.2 Asia-Pacific Flu Shots Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Flu Shots Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Flu Shots Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 SANOFI
8.1.1 SANOFI Comapny Information
8.1.2 SANOFI Business Overview
8.1.3 SANOFI Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 SANOFI Flu Shots Product Portfolio
8.1.5 SANOFI Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 GSK Flu Shots Product Portfolio
8.2.5 GSK Recent Developments
8.3 VAXTEC
8.3.1 VAXTEC Comapny Information
8.3.2 VAXTEC Business Overview
8.3.3 VAXTEC Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 VAXTEC Flu Shots Product Portfolio
8.3.5 VAXTEC Recent Developments
8.4 TIANYUAN BIO-PHARMA
8.4.1 TIANYUAN BIO-PHARMA Comapny Information
8.4.2 TIANYUAN BIO-PHARMA Business Overview
8.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
8.4.5 TIANYUAN BIO-PHARMA Recent Developments
8.5 SIOBP
8.5.1 SIOBP Comapny Information
8.5.2 SIOBP Business Overview
8.5.3 SIOBP Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 SIOBP Flu Shots Product Portfolio
8.5.5 SIOBP Recent Developments
8.6 SINOVAC
8.6.1 SINOVAC Comapny Information
8.6.2 SINOVAC Business Overview
8.6.3 SINOVAC Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 SINOVAC Flu Shots Product Portfolio
8.6.5 SINOVAC Recent Developments
8.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
8.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Comapny Information
8.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
8.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
8.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
8.8 HUALAN BIO
8.8.1 HUALAN BIO Comapny Information
8.8.2 HUALAN BIO Business Overview
8.8.3 HUALAN BIO Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 HUALAN BIO Flu Shots Product Portfolio
8.8.5 HUALAN BIO Recent Developments
8.9 CHANGSHENG
8.9.1 CHANGSHENG Comapny Information
8.9.2 CHANGSHENG Business Overview
8.9.3 CHANGSHENG Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 CHANGSHENG Flu Shots Product Portfolio
8.9.5 CHANGSHENG Recent Developments
8.10 CCBIO
8.10.1 CCBIO Comapny Information
8.10.2 CCBIO Business Overview
8.10.3 CCBIO Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 CCBIO Flu Shots Product Portfolio
8.10.5 CCBIO Recent Developments
8.11 ALEPH BIOMEDICAL
8.11.1 ALEPH BIOMEDICAL Comapny Information
8.11.2 ALEPH BIOMEDICAL Business Overview
8.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
8.11.5 ALEPH BIOMEDICAL Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Flu Shots Value Chain Analysis
9.1.1 Flu Shots Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Flu Shots Production Mode & Process
9.2 Flu Shots Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Flu Shots Distributors
9.2.3 Flu Shots Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.